Azlocilline [INN-French] en es it fr

Azlocilline [INN-French] Brand names, Azlocilline [INN-French] Analogs

Azlocilline [INN-French] Brand Names Mixture

  • No information avaliable

Azlocilline [INN-French] Chemical_Formula


Azlocilline [INN-French] RX_link

No information avaliable

Azlocilline [INN-French] fda sheet

Azlocilline [INN-French] msds (material safety sheet)

Azlocilline_[INN-French] MSDS

Azlocilline [INN-French] Synthesis Reference

No information avaliable

Azlocilline [INN-French] Molecular Weight

461.493 g/mol

Azlocilline [INN-French] Melting Point

No information avaliable

Azlocilline [INN-French] H2O Solubility

Sodium salt is soluble in water (50 mg/ml)

Azlocilline [INN-French] State


Azlocilline [INN-French] LogP


Azlocilline [INN-French] Dosage Forms

Solution (for intramuscular injection or intravenous infusion)

Azlocilline [INN-French] Indication

For the treatment of infections caused by Pseudomonas aeruginosa, Escherichia coli, and Haemophilus influenzae.

Azlocilline [INN-French] Pharmacology

Azlocillin, similar to mezlocillin and piperacillin, is an acylampicillin with an extended spectrum of activity and greater in vitro potency than the carboxy penicillins. Azlocillin demonstrates antibacterial activity against a broad spectrum of bacteria, including Pseudomonas aeruginosa, and, in contrast to most cephalosporins, exhibits activity against enterococci.

Azlocilline [INN-French] Absorption

Not significantly absorbed from the gastrointestinal tract.

Azlocilline [INN-French] side effects and Toxicity

No information avaliable

Azlocilline [INN-French] Patient Information

Azlocilline [INN-French] Organisms Affected

Enteric bacteria and other eubacteria